TMEM175 agonist(Mair Therapeutics BV)

N/A

Report date: 2026/03/07 20:00:27
NMEFirst In Class

Base Information

Drug NameTMEM175 agonist(Mair Therapeutics BV)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionEndosomal/lysosomal potassium channel TMEM175 agonists
TargetsEndosomal/lysosomal potassium channel TMEM175
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMair Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesRadboud UniversityMair Therapeutics BV
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A